Brii Biosciences Limited
BRIBF
$0.2406
$0.00944.07%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | 1.93M | 1.94M | 1.53M | 1.54M | 1.09M |
| Total Revenue | 1.93M | 1.94M | 1.53M | 1.54M | 1.09M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.93M | 1.94M | 1.53M | 1.54M | 1.09M |
| SG&A Expenses | 6.42M | 6.45M | 7.70M | 7.77M | 6.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.02M | 15.09M | 16.42M | 16.56M | 20.38M |
| Operating Income | -13.09M | -13.15M | -14.89M | -15.02M | -19.28M |
| Income Before Tax | -15.93M | -16.00M | -19.56M | -19.73M | 862.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.93M | -16.00M | -19.56M | -19.73M | 862.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 105.40K | 105.90K | 186.60K | 188.20K | 182.30K |
| Net Income | -15.82M | -15.90M | -19.37M | -19.54M | 1.04M |
| EBIT | -13.09M | -13.15M | -14.89M | -15.02M | -19.28M |
| EBITDA | -13.01M | -13.04M | -14.73M | -14.85M | -19.12M |
| EPS Basic | -0.02 | -0.02 | -0.03 | -0.03 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.02 | -0.02 | -0.03 | -0.03 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 730.78M | 730.78M | 729.71M | 729.71M | 728.71M |
| Average Diluted Shares Outstanding | 730.78M | 730.78M | 729.71M | 729.71M | 728.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |